| IVITX | VIVAX | IVITX / VIVAX | |
| Total Expense Ratio | 1.04 | 0.17 | 612% |
| Annual Report Gross Expense Ratio | 1.04 | 0.17 | 612% |
| Fund Existence | 23 years | 33 years | - |
| Gain YTD | 4.177 | 5.998 | 70% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 168M | 218B | 0% |
| Annual Yield % from dividends | 0.45 | 1.84 | 24% |
| Returns for 1 year | -6.25 | 15.07 | -41% |
| Returns for 3 years | 0.20 | 41.03 | 0% |
| Returns for 5 years | 5.37 | 66.25 | 8% |
| Returns for 10 years | 9.35 | 167.20 | 6% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| QTELX | 14.38 | 0.17 | +1.20% |
| AQR Emerging Multi-Style II I | |||
| KCSIX | 14.24 | 0.01 | +0.07% |
| Knights of Columbus Small Cap I | |||
| SBHIX | 26.29 | -0.26 | -0.98% |
| Saratoga Health & Biotechnology I | |||
| MAFOX | 8.37 | -0.15 | -1.76% |
| BlackRock Large Cap Focus Growth Instl | |||
| HGOFX | 69.14 | -1.35 | -1.92% |
| Hartford Growth Opportunities F | |||